Diana Carolina López-Medina

Diana Carolina López-Medina

Auto-generated profile, based on publicly available information

Diana Carolina López-Medina

Universidad Cooperativa de Colombia Medellín Colombia ucc.edu.co

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2023 in Journal of Thermal Biology
Verified
Journal Article
Closed access
VTVictor Hugo Aristizabal Tique
Victor Hugo Aristizabal Tique
MHMarcela Henao-Perez
Marcela Henao-Perez
DLDiana Carolina López-Medina
Diana Carolina López-Medina
RZRenato Zambrano
Renato Zambrano
GDGloria Díaz-Londoño
Gloria Díaz-Londoño

14 March 2025 in BMC Neurology
Verified
Journal Article
Open access
PDF file
DLDiana Carolina López-Medina
Diana Carolina López-Medina
AAAlejandra Arboleda-Ramírez
Alejandra Arboleda-Ramírez
SRSara Ríos-Díaz
Sara Ríos-Díaz
RZRenato Zambrano
Renato Zambrano
AAAndrés Arboleda-Jaramillo
Andrés Arboleda-Jaramillo
MHMarcela Henao-Perez
Marcela Henao-Perez
Migraine is a highly prevalent and disabling condition, not only due to its painful symptoms but also because of its significant impact on mental health and cognitive functioning, leading to a considerable deterioration in quality of life. This study aimed to evaluate the cognitive profile, mental health, and quality of life in patients with chronic and episodic migraine during the interictal period, and to explore their relationship with sociodemographic and clinical variables. This observational, descriptive, cross-sectional analytical study included 60 patients diagnosed with chronic or episodic migraine, who were enrolled in a health program for headache patients between 2010 and 2016. Cognitive function, anxiety and/or depression symptoms, and quality of life during the interictal period were assessed. Descriptive analyses were conducted, and associations were evaluated by configuring primary (type of migraine) and alternative events (cognitive impairment, depression and/or anxiety, and poor quality of life). The mean age of the participants was 45 years (SD ± 8), with 83.3% being women and 93.3% belonging to middle and low socioeconomic strata. Of the 60 patients, 83.3% (50) were diagnosed with chronic migraine, while the remaining had episodic migraine. The use of one or more cognition-altering medications was observed in 90% of patients with chronic migraine and 60% of those with episodic migraine (p = 0.02). Anxiety was more prevalent in patients with episodic migraine, whereas depression was more common among those with chronic migraine. Female gender, middle socioeconomic status, and longer disease duration were significantly associated with chronic migraine. Among the 57 patients who completed the Mini-Mental State Examination, 38.6% had cognitive impairment, which decreased with longer migraine duration and better social interaction. Memory and selective attention were the most affected cognitive domains in both groups. No significant associations were found for the other variables after adjusting for confounders. Chronic migraine significantly impacts mental health, cognition, and quality of life, with depression and cognitive impairments being prevalent. Social interaction and longer disease duration may protect against cognitive decline, highlighting the need for multidisciplinary, personalized interventions addressing neurological and psychosocial challenges.

27 May 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
DMDiana Carolina López Medina
Diana Carolina López Medina
AOAida Oliveros-Navarro
Aida Oliveros-Navarro
NMNataly Moreno-Ángel
Nataly Moreno-Ángel
AAAndrés Camilo Herrera- Arellano
Andrés Camilo Herrera- Arellano
MHMarcela Henao-Perez
Marcela Henao-Perez
Background: AI shows substantial potential in health care; however, the absence of standardized evaluation frameworks limits its safe and effective clinical implementation because of inconsistent validation requirements and fragmented ethical principles. Existing guidelines vary in structure, methodological rigor, and ethical integration, creating uncertainty. Objective: This study aimed to systematically map, characterize, and critically analyze existing evaluation frameworks for clinical AI, focusing on three core dimensions: methodological rigor, validation strategies (internal validation, including reporting of technical and clinical performance; external validation, including real-world applicability), and alignment with the United Nations Educational, Scientific and Cultural Organization (UNESCO) AI ethical considerations. Methods: A scoping review was conducted following PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines. Six databases (PubMed, Embase, BVS, EBSCOhost, ProQuest, and Sage) and the Enhancing the Quality and Transparency of Health Research Network were searched without language or date restrictions up to February 2026. Eligible documents included peer-reviewed papers, gray literature, and organizational guidelines describing evaluation or reporting frameworks for clinical AI. Editorials, commentaries, and conference abstracts lacking a clearly defined evaluative framework or clinical applicability were excluded. Two reviewers independently screened records and extracted data. Data were extracted across three domains: (1) general characteristics, (2) methodological rigor and validation parameters, and (3) ethical integration and were synthesized using a dot plot–based gap map. Ethical adherence was assessed using a 10-domain UNESCO-based scoring matrix. No formal risk-of-bias assessment was conducted, consistent with scoping review methodology. Results: From 3363 records, 46 frameworks met the inclusion criteria. Mapping revealed a rapidly expanding but fragmented landscape. Most frameworks targeted investigational use (88%), with limited focus on clinical applicability. Frameworks varied in structure, methodology, and scope, with a predominance of reporting guidelines and few validated tools. Most (63%) were developed through multi-institutional collaborations, and 32.6% incorporated transdisciplinary participation. Only 31.8% reported technical metrics (commonly area under the curve, sensitivity, and specificity), and 15.9% provided clinical indicators (eg, predictive values or calibration). Only 11.4% achieved methodological rigor, incorporating validation aligned with intended use, while most relied on partial validation strategies, highlighting a gap between model development and clinical evaluation. Ethical integration was heterogeneous: only 5 frameworks achieved high compliance (≥80%), whereas 4 scored <10%. The most frequently addressed UNESCO principles were awareness and education (71.1%) and transparency and explainability (70%), while human oversight (24.4%) and adaptive governance (33.3%) were least represented. Findings indicate a misalignment between framework design, validation requirements, and clinical implementation. Conclusions: Evaluation frameworks for clinical AI remain heterogeneous and oriented toward investigational contexts. Critical gaps persist in methodological rigor, validation aligned with intended use, and fragmented ethical coverage. These findings highlight the need for standardized, robust, and ethically grounded frameworks to enable safe, reliable, and scalable integration of AI into clinical practice.

1 January 2020 in Revista Brasileira de Terapia Intensiva
Verified
Journal Article
Open access
PDF file
DLDiana Carolina López-Medina
Diana Carolina López-Medina
MHMarcela Henao-Perez
Marcela Henao-Perez
JAJaime Arenas-Andrade
Jaime Arenas-Andrade
EHEmel David Hinestroza-Marín
Emel David Hinestroza-Marín
FJFabián Alberto Jaimes-Barragán
Fabián Alberto Jaimes-Barragán
OQOscar Iván Quirós-Gómez
Oscar Iván Quirós-Gómez
To explore the association between demographic and clinical factors and the presentation of septic shock in patients treated by prehospital emergency services in five Colombian cities between 2015 and 2016. This was a cross-sectional study with retrospective data collection. Clinical and demographic data were collected from the medical records of patients diagnosed with sepsis who received prehospital care in five Colombian cities in 2015 and 2016. The diagnosis of septic shock was checked in 20% of the cases, generating two analyzed scenarios: observed and verified. Data were analyzed using the chi-square test, Student's t test and an adjusted logistic regression model. Covariates with p < 0.05 were considered significant. There was a higher frequency of septic shock in women (62.6%) and in individuals older than 80 years (64.5%), but these were not differentiating factors for septic shock. The most common source of infection was the urinary tract. In the observed scenario, age over 60 (prevalence ratio (PR): 3.22; 95% confidence interval (CI): 1.45 - 35.01) and history of cancer (PR: 1.20; 95%CI: 1.2 - 12.87) were the characteristics associated with septic shock, whereas in the verified scenario, chronic obstructive pulmonary disease (PR: 1.99; 95%CI: 1.26 - 7.14), history of cancer (PR: 1.15; 95%CI: 1.11 - 6.62) and presence of hypovolemia (PR: 1.41; 95%CI: 1.02 - 5.50) were observed. The most important risk factors for septic shock in prehospital care patients in five Colombian cities were oncological and pulmonary diseases and hypovolemia.

1 July 2024 in Luna Azul
Verified
Journal Article
Open access
PDF file
DMDiana Carolina López Medina
Diana Carolina López Medina
MHMarcela Henao-Perez
Marcela Henao-Perez
VTVictor Hugo Aristizabal Tique
Victor Hugo Aristizabal Tique
La contaminación atmosférica tiene una gran influencia en la salud y bienestar del ser humano, considerada uno de los principales factores de riesgo que favorece la presencia de enfermedades cardiorrespiratorias. Bello es un municipio del Valle de Aburrá, situado en la desembocadura de la cuenca hidrográfica. Su ubicación geográfica, junto con una alta densidad poblacional, una intensa actividad industrial y un importante tráfico vehicular, crea condiciones que pueden agravar la degradación ambiental y aumentar la exposición a contaminantes atmosféricos. El objetivo de este estudio fue correlacionar los valores medidos de contaminantes criterio con el número de consultas según localización y presentación (aguda o crónica) de las enfermedades respiratorias, en los meses de contingencia atmosférica en los años 2016 y 2017. Metodología: cuantitativo, observacional, retrospectivo, tipo ecológico, exploratorio correlacional por tiempo de latencia entre la exposición al factor ambiental y consulta médica por afecciones clínicas del tracto respiratorio. Resultados: el tiempo de latencia entre la exposición y las consultas para enfermedad respiratoria baja aguda se dio luego del segundo día de exposición al PM 2.5 y PM 10; para enfermedad respiratoria baja crónica-agudizada se aumentaron las consultas por exposiciones a PM 2.5 al quinto día y para enfermedad respiratoria alta aguda luego del sexto día de exposición a NOx, PM 2.5 y PM 10. Conclusiones: La exposición a PM 2.5 se relacionó con la presentación de enfermedades del tracto respiratorio alto y bajo tanto agudas como crónicas. El PM 10 se relacionó con las enfermedades agudas del tracto respiratorio alto y bajo, mientras que la exposición a NOx se asoció solo a patologías del tracto respiratorio alto. Los resultados sugieren una posible asociación entre los contaminantes criterio y la morbilidad respiratoria. Aunque no se puede establecer causalidad, estos resultados podrían orientar políticas públicas de control ambiental enfocadas en la protección de la salud y la equidad.

1 January 2026 in Neurology Research International
Verified
Journal Article
Open access
MHMarcela Henao-Perez
Marcela Henao-Perez
DLDiana Carolina López-Medina
Diana Carolina López-Medina
AAAlejandra Arboleda-Ramírez
Alejandra Arboleda-Ramírez
ZBZahian Barroso-Barrera
Zahian Barroso-Barrera
JLJuan Pablo Londoño-Aristizábal
Juan Pablo Londoño-Aristizábal
Background: Progressive supranuclear palsy (PSP) is a rare 4‐repeat tauopathy characterized by marked clinical heterogeneity and frequent diagnostic delay. Epidemiological and phenotypic data from Latin America remain limited. This study aimed to describe the clinical and epidemiological characteristics of PSP in a Colombian referral center and to compare findings by sex and phenotype. Methods: We retrospectively reviewed PSP cases evaluated at a Colombian neurological referral center from 2013 to 2023. Demographic, clinical, neuroimaging, diagnostic, and treatment‐related variables were extracted from medical records. PSP phenotypes were retrospectively classified and grouped using clinical information from medical records. Period prevalence was estimated using the adult population of Antioquia as the denominator. Results: Among 152 patients, 53.9% were male. Crude period prevalence was 1.8 per 100,000 adults, peaking at 75–84 years. Women were older than men at evaluation, whereas age at symptom onset was similar between sexes. Mean diagnostic delay was approximately 3.5 years. Postural instability was the most frequent presenting symptom. PSP‐Richardson syndrome and PSP‐parkinsonism were the most common phenotypes. MRI was the most frequently requested imaging study, and midbrain atrophy was the most common abnormality. Levodopa/carbidopa was the most frequently prescribed medication, with documented initial response in only a subset of treated patients. Conclusions: PSP in this Colombian cohort predominantly affected older adults and was characterized by substantial diagnostic delay, marked phenotypic heterogeneity, and predominantly symptomatic treatment. These findings expand the limited Latin American literature and underscore the need for earlier recognition of both typical and atypical PSP presentations.